A5101701132- Gastric Cancer Management and Outcomes
- Metastasis and carcinoma case studies
- Colorectal and Anal Carcinomas
- Caveolin-1 and cellular processes
- Inflammatory Biomarkers in Disease Prognosis
- Neuroendocrine Tumor Research Advances
- Cancer, Lipids, and Metabolism
- Berberine and alkaloids research
- Fibroblast Growth Factor Research
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Lung Cancer Research Studies
Shanxi Fenyang Hospital
2023-2025
Shanxi Medical University
2023-2025
Background Gastric cancer represents a highly aggressive form of malignant tumor originating from the epithelial cells lining gastric mucosa. Despite notable improvements in treatment approaches over last few years, associated mortality rate continues to be considerably high. Therefore, there is pressing requirement for dependable biomarkers that can utilized predict and monitor prognosis, as well formulate targeted strategies patient groups at high risk. Methods We conducted an analysis...
Abstract Background As one of the most malignant tumors digestive tract, gastric cancer has a high incidence rate and mortality in recent years, lacks significant prognostic indicators. D-dimer, as degradation product fibrin, is conventional biomarker for coagulation been studied to have potential promoting effects on postoperative patients. However, there are also contradictory results, with some studies reporting effect, while others not shown any effect. Therefore, actual impact D-dimer...
Gastric cancer, one of the most aggressive tumors affecting digestive tract, has seen a rise in both incidence and mortality rates recent years, with lack clear prognostic indicators. D‑dimer, byproduct fibrin degradation, is conventional coagulation biomarker that been investigated as potential adverse factor for postoperative cancer patients. However, conflicting results exist, some studies suggesting D‑dimer an independent risk prognosis gastric others there no significant association...